421 related articles for article (PubMed ID: 1656258)
1. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
3. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
5. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
[TBL] [Abstract][Full Text] [Related]
7. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
9. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.
Alter MJ; Margolis HS; Krawczynski K; Judson FN; Mares A; Alexander WJ; Hu PY; Miller JK; Gerber MA; Sampliner RE
N Engl J Med; 1992 Dec; 327(27):1899-905. PubMed ID: 1280771
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
[TBL] [Abstract][Full Text] [Related]
13. [Serologic and genomic markers of the hepatitis C virus in transfusion recipients with non-A, non-B hepatitis].
Soriano V; Pauplana M; Nedjar S; Tor J; Hewlett I; Ribera A; Pujol M; Soria C; Biswas R
Med Clin (Barc); 1991 Dec; 97(20):764-8. PubMed ID: 1665532
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
15. Transmission of hepatitis C virus by organ transplantation.
Pereira BJ; Milford EL; Kirkman RL; Levey AS
N Engl J Med; 1991 Aug; 325(7):454-60. PubMed ID: 1649402
[TBL] [Abstract][Full Text] [Related]
16. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.
Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
19. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
20. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
